DR4 MEF, P2, untreated, 1 vial of 1
Order now: dominika@ksiazkiwnauce.pl
DR4 MEF, P3, mitomycin-C treated, 1 vial of 4^106 cells |
|||
| ASF-1023 | Applied StemCell | 1 vial of 4 x 10^6 cells | 107.63 EUR |
|
Description: 6 month |
|||
DR4 MEF, P3, mitomycin-C treated, 1 vial of 2^106 cells |
|||
| ASF-1025 | Applied StemCell | 1 vial of 2 x 10^6 cells | 87.97 EUR |
|
Description: 6 month |
|||
DR4 MEF, P3, irradiated, 5 vial of 2^106 cells |
|||
| ASF-1016 | Applied StemCell | 5 vials of 2 x 10^6 cells | 189.28 EUR |
|
Description: 6 month |
|||
DR4 MEF, P3, mitomycin-C treated, 5 vial of 2^106 cells |
|||
| ASF-1026 | Applied StemCell | 5 vials of 2 x 10^6 cells | 189.28 EUR |
|
Description: 6 month |
|||
CF1 MEF, P3, irradiated, 1 vial of 1^106 cells |
|||
| ASF-1217 | Applied StemCell | 1 vial of 1 x 10^6 cells | 69.07 EUR |
|
Description: 6 month |
|||
CF1 MEF, P3, irradiated, 1 vial of 4^106 cells |
|||
| ASF-1213 | Applied StemCell | 1 vial of 4 x 10^6 cells | 78.14 EUR |
|
Description: 6 month |
|||
CF1 MEF, P3, irradiated, 1 vial of 2^106 cells |
|||
| ASF-1215 | Applied StemCell | 1 vial of 2 x 10^6 cells | 73.99 EUR |
|
Description: 6 month |
|||
CORNING® UNTREATED MICROCARRIERS, 1 VIAL, 100 G |
|||
| 4624 | CORNING | 100g/pk | 837.6 EUR |
|
Description: Microcarriers; Corning Microcarriers |
|||
CORNING® UNTREATED MICROCARRIERS, 1 VIAL, 500 G |
|||
| 4625 | CORNING | 500g/pk | 3133.2 EUR |
|
Description: Microcarriers; Corning Microcarriers |
|||
CORNING® UNTREATED MICROCARRIERS, 1 VIAL, 10 G |
|||
| 3772 | CORNING | 10g/pk | 117.6 EUR |
|
Description: Microcarriers; Corning Microcarriers |
|||
Neo resistant MEF, P3, irradiated, 1 vial of 4^106 cells |
|||
| ASF-1113 | Applied StemCell | 1 vial of 4 x 10^6 cells | 78.14 EUR |
|
Description: 6 month |
|||
Neo resistant MEF, P3, irradiated, 1 vial of 2^106 cells |
|||
| ASF-1115 | Applied StemCell | 1 vial of 2 x 10^6 cells | 73.99 EUR |
|
Description: 6 month |
|||
CF1 MEF, P3, mitomycin-C treated, 1 vial of 4^106 cells |
|||
| ASF-1223 | Applied StemCell | 1 vial of 4 x 10^6 cells | 78.14 EUR |
|
Description: 6 month |
|||
CF1 MEF, P3, mitomycin-C treated, 1 vial of 2^106 cells |
|||
| ASF-1225 | Applied StemCell | 1 vial of 2 x 10^6 cells | 73.99 EUR |
|
Description: 6 month |
|||
DR4 MEF, P3, irradiated, 5 vials of 4^106 cells |
|||
| ASF-1014 | Applied StemCell | 5 vials of 4 x 10^6 cells | 278.48 EUR |
|
Description: 6 month |
|||
Neo resistant MEF, P3, mitomycin-C treated, 1 vial of 4^106 cells |
|||
| ASF-1123 | Applied StemCell | 1 vial of 4 x 10^6 cells | 78.14 EUR |
|
Description: 6 month |
|||
Neo resistant MEF, P3, mitomycin-C treated, 1 vial of 2^106 cells |
|||
| ASF-1125 | Applied StemCell | 1 vial of 2 x 10^6 cells | 73.99 EUR |
|
Description: 6 month |
|||
DR4 MEF, P3, mitomycin-C treated, 5 vials of 4^106 cells |
|||
| ASF-1024 | Applied StemCell | 5 vials of 4 x 10^6 cells | 278.48 EUR |
|
Description: 6 month |
|||
PiranhaTM HEK293T GFP/Puromycin Stable Cell Line (>1x10^6 cell/vial) |
|||
| PTPD600A-1 | SBI | 1 vial | 1358.4 EUR |
Rat/Mouse Myelin Oligodendrocyte Glycoprotein 35-55 aa peptide pure (Ac/amide form) |
|||
| MOG3555-P2-1 | Alpha Diagnostics | 1 mg | 343.2 EUR |
Human Inhibitor of Growth Protein 1 (ING1) AssayMax ELISA Kit |
|||
| EI1770-1 | AssayPro | 96 Well Plate | 572.4 EUR |
TIMP1 Human, Tissue Inhibitor of Metalloprotease 1 Human Recombinant Protein, HEK |
|||
| PROTP01033-1 | BosterBio | Regular: 10ug | 380.4 EUR |
|
Description: TIMP1 Human Recombinant produced in HEK-293 cells is a secreted protein with the sequence of Human TIMP-1 (amino acids Cys24-Ala207) and fused to a polyhistidine tag at the C-terminus. |
|||
BSA and BGG Stock standards (1 vial each @ 2 mg/ml) for BCA Optima Protein Assay kit |
|||
| BSA-BGG-1 | Alpha Diagnostics | 1 pk | 343.2 EUR |
Custom production of antibodies in 1 Goat using supplied antigen (std 63 days protocol) |
|||
| GOT-1 | Alpha Diagnostics | 1 | 2252.4 EUR |
Custom production of antibodies in 1 Rabbit using supplied antigen (std 63 days protocol) |
|||
| RAB-1 | Alpha Diagnostics | 1 | 790.8 EUR |
Custom production of antibodies in 1 Sheep using supplied antigen (std 63 days protocol) |
|||
| SHP-1 | Alpha Diagnostics | 1 | 2252.4 EUR |
Saponins vaccine adjuvant Combo Pak-1 (contains 1mg of QS21,100 mg of Vet-SAP and 1 g of Saponin). |
|||
| AV-4000-PK-1 | Alpha Diagnostics | 1 pk | 634.8 EUR |
Neuregulin/Heregulin-1? (NRG-1?/HRG-1?), human recombinant protein |
|||
| P1054-1 | ApexBio | 1 mg | 4736.4 EUR |
|
Description: Neuregulin (NRG) is a signaling protein for ErbB2/ErbB4 receptor heterodimers on the cardiac muscle cells and plays an important role in heart structure and function through inducing cardiomyocyte differentiation |
|||
Haptoglobin, (Phenotype 1-1) Human Plasma |
|||
| 7536-1 | Biovision | 385.2 EUR | |
Endothelin-1 (1-15), amide, human |
|||
| A1111-1 | ApexBio | 1 mg | 866.4 EUR |
|
Description: Endothelins are 21-amino acid vasoconstricting peptides produced primarily in the endothelium and have a key role in vascular homeostasis. |
|||
Angiotensin 1/2 (1-7) amide |
|||
| A1054-1 | ApexBio | 1 mg | 115.2 EUR |
|
Description: Angiotensin I/II (1-7) amide (H2N-Asp-Arg-Val-Tyr-Ile-His-Pro-amide) is a peptide analog to angiotensin II that is used as a vasopressor in the treatment of certain types of shock and circulatory collapse. |
|||
Angiotensin 1/2 (1-8) amide |
|||
| A1055-1 | ApexBio | 1 mg | 115.2 EUR |
|
Description: The physiologically active peptide angiotensin-2 (angiotensin 1- 8) is yielded from angiotensin-1, a substrate of ACE (angiotensin converting enzyme), by removing a dipeptide. |
|||
GYRKPLDNIKDNVGKMEDYIKK, MSP-1 P2, peptide of P. falciparum Merozoite Surface Protein 1 |
|||
| MSPF12-P | Alpha Diagnostics | 1 mg | 270 EUR |
UK 1 |
|||
| C5006-1 | ApexBio | 1 mg | 435.6 EUR |
|
Description: UK 1, an unusual bis-benzoxazole metabolite isolated from Streptomyces sp. 517-02, is an inhibitor of topoisomerase II (Topo II) and hepatitis C viral replication. |
|||
KP372-1 |
|||
| C5053-1 | ApexBio | 1 mg | 158.4 EUR |
|
Description: IC50: 30-60 nM for thyroid cancer cells KP372-1 is a specific Akt inhibitor. The phosphatidylinositol 3' kinase (PI3K)/phosphatase, which is a key regulator of cell proliferation and survival, is mutated or activated in various cancers. |
|||
IDE-1 |
|||
| 2193-1 | Biovision | 176.4 EUR | |